Redica Systems has been assisting pharmaceutical companies in determining GMP quality risks at their manufacturing sites, and with AI, it has a relatively new addition to its toolbox.

The agency’s CHMP recommended drugs to treatments for hemophilia, two biosimilars for psoriasis, and two flu vaccines at their October meeting.

Xiao-Yan Cai, PhD, co-founder and CEO of Accurant Biotech, discussed collaborative efforts that must be undertaken between companies, and across scientific disciplines, to work together on continuing ...

The agency has reconfirmed its recommendation to not give positive opinion to Translarna (ataluren) after a reexamination of the available data.

Regulators, EMA and HMA, have published principles and recommendations on the use of LLMs, which are being increasingly used ...

For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective ...

The design of the center prioritizes integration of the entire supply chain, with the end goals of accelerating product development and autonomous production capacity in alignment with EU priorities.

The global CRDMO said its clients would be able to expedite R&D processes, thereby reducing costs and potentially leading to accelerated discovery of new candidate therapies. BioDuro-Sundia, a ...

Ahmed Youssef, senior manager, USP Process Development at Ascend, provides insight on tech transfer when developing and manufacturing emerging therapies and new modalities. Pharmaceutical Technology® ...

The draft joint network strategy for the EU until 2028 will be open for public consultation until Nov. 30, 2024. The European Medicines Agency (EMA) and the Heads of Medicines Agency (HMA) announced ...

“Episode 1: Cell and Gene Therapy” features the expertise of Dr. Fabian Gerlinghaus, co-founder and chief executive officer of Cellares; Dr. Claudia Zylberberg, board chair and co-founder of Arscience ...